News Breaks |
|
|
| October 2, 2012 |
| 06:32 EDT |  | VASC | Vascular Solutions price target raised to $17 from $15 at Benchmark Co.
Benchmark Co. believes Vascular Solutions' new product visibility remains strong and keeps a Buy rating on the stock with an increased price target. |
|
|
News For VASC From The Last 14 Days Check below for free stories on VASC the last two weeks. |
|
|
| May 16, 2013 |
| 16:13 EDT |  | VASC | Vascular Solutions files patent infringement complaint against Boston Scientific
Vascular Solutions (VASC) announced that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (BSX). The complaint alleges that Boston Scientific has infringed three patents owned by Vascular Solutions concerning rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter which received 510(k) clearance in March. Vascular Solutions is seeking an injunction against Boston Scientific prohibiting the manufacture and sale of its Guidezilla catheter as well as damages for lost profits and legal costs. |
|
|
|
|
|
